论文部分内容阅读
目的探讨甲氨蝶呤配伍米非司酮治疗剖宫产瘢痕妊娠(CSP)致胚胎死亡后行清宫术的可行性。方法收集我院2008年1月-2013年1月间收治的9例CSP患者的诊治经过,均采取甲氨蝶呤配伍米非司酮保守治疗。结果其中7例致胚胎死亡行清宫术,1例行子宫动脉栓塞后行清宫术,1例行开腹手术,切除病灶,子宫修补,9例均保留子宫。结论甲氨蝶呤配伍米非司酮治疗CSP致胚胎死亡后行清宫术能迅速终止妊娠,预防大出血,保留患者子宫,可作为CSP主要的保守疗法。
Objective To investigate the feasibility of methotrexate with mifepristone in the treatment of cesarean scar pregnancy (CSP) caused by embryo after the death of curettage feasibility. Methods Nine patients with CSP admitted to our hospital from January 2008 to January 2013 were treated with methotrexate and mifepristone conservatively. Results Among them, 7 cases had embryos died of curettage, 1 case of uterine artery embolization after radical curettage, 1 case of laparotomy, resection of lesions, uterine repair, and 9 cases of uterus. Conclusion Methotrexate combined with mifepristone treatment of CSP caused by embryo death after cesarean section can terminate the pregnancy quickly to prevent bleeding and retain the patient’s uterus, CSP can be used as the main conservative treatment.